1. Home
  2. AFYA vs NNNN Comparison

AFYA vs NNNN Comparison

Compare AFYA & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Afya Limited

AFYA

Afya Limited

HOLD

Current Price

$14.51

Market Cap

1.3B

Sector

Real Estate

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$10.00

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AFYA
NNNN
Founded
1999
2021
Country
Brazil
Germany
Employees
9395
27
Industry
Other Consumer Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
AFYA
NNNN
Price
$14.51
$10.00
Analyst Decision
Hold
Analyst Count
5
0
Target Price
$17.00
N/A
AVG Volume (30 Days)
125.4K
44.9K
Earning Date
05-08-2026
04-07-2026
Dividend Yield
4.90%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.43
N/A
Revenue Next Year
$7.15
N/A
P/E Ratio
$9.30
$446.57
Revenue Growth
N/A
N/A
52 Week Low
$13.00
$10.50
52 Week High
$16.47
$55.65

Technical Indicators

Market Signals
Indicator
AFYA
NNNN
Relative Strength Index (RSI) 48.19 23.86
Support Level $14.24 N/A
Resistance Level $14.77 $30.21
Average True Range (ATR) 0.42 2.12
MACD -0.02 -0.00
Stochastic Oscillator 29.14 17.53

Price Performance

Historical Comparison
AFYA
NNNN

About AFYA Afya Limited

Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergraduate, deriving key revenue provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

Share on Social Networks: